The emerging market for sepsis therapeutics and preventive agents.
Read Online
Share

The emerging market for sepsis therapeutics and preventive agents.

  • 993 Want to read
  • ·
  • 55 Currently reading

Published by Find/SVP in New York .
Written in English

Subjects:

  • Anti-infective agents industry.,
  • Septicemia -- Chemotherapy.,
  • Market surveys.

Book details:

Edition Notes

SeriesA market intelligence report, Market intelligence report (New York, N.Y.)
ContributionsFind/SVP (Firm)
Classifications
LC ClassificationsHD9675.A5452 E46 1995
The Physical Object
Paginationviii, 160 p. ;
Number of Pages160
ID Numbers
Open LibraryOL287218M
ISBN 101562412876
LC Control Number97190811
OCLC/WorldCa41600744

Download The emerging market for sepsis therapeutics and preventive agents.

PDF EPUB FB2 MOBI RTF

Sepsis Diagnostics Market is poised to grow at a CAGR of % by The Sepsis Diagnostics market is segmented by Technology (Molecular Diagnostics, Microbiology, Immunoassay, and Other Technologies), Product, Diagnostic Method, Pathogen, and Geography. Sepsis Therapeutics Market: Overview. According to the latest report published by Transparency Market Research on the global sepsis therapeutics market for the historical year of and forecast period of to , rise in investments in research & development and novel pipeline drugs are projected to boost the growth of the global sepsis therapeutics market during the forecast period/5(10). The sepsis therapeutics market can be categorized on the basis of drug class and region. On the basis of drug class, the market can be segmented into aminoglycosides, colony stimulating factors. The global sepsis diagnostic market size was valued at USD million in and is expected to witness attractive growth over the forecast period. Factors such as high prevalence of sepsis, increasing awareness, and introduction of technologically advanced diagnostic solutions are expected to significantly fuel market growth over the forecast period.

The sepsis and septic shock space across the seven major pharmaceutical markets (7MM) of the US, 5EU (France, Germany, Italy, Spain, and the UK), and Japan is set to grow from $ billion in to $ billion by , representing a compound annual growth rate (CAGR) of %, according to GlobalData, a recognized leader in providing business information and analytics.   The sepsis treatment market has been valued at $5 billion and is forecast to achieve a valuation of $ billion by , according to a new repo Sepsis Treatment Market . Emerging Pathophysiological Targets of Psoriasis for Future Therapeutic Strategies, - Monu Yadav*, Ishu Sardana, Amarjeet Sharma, Nidhi Sharma, Kalpana Nagpal* and Paramjeet Malik DOI: /   Sepsis Definitions. The term sepsis originates from an ancient Greek word sepsis, which means the “decay of organic matter,” and was first known to be used in an Egyptian papyrus circa b.c.[]The modern definition of sepsis was created in by a consensus conference of the American College of Chest Physicians (ACCP) and the Society of Critical Care Medicine (SCCM), so that.

The sepsis diagnostics market, by technology, the market is segmented into blood culture, immunoassays, molecular diagnostics, flow cytometry, microfluidics, and biomarkers. In , the blood culture segment accounted for the largest share of the market.   Global Sepsis Therapeutics Market: Introduction. In terms of revenue, the global sepsis therapeutics market is projected to expand at a CAGR of % during the forecast period due to numerous factors, about which, TMR offers comprehensive insights and forecasts in the global sepsis therapeutics market report.. Sepsis, also known as septicemia, is a life-threatening disease caused . This market research report on the global sepsis therapeutics market also provides an analysis of the most important trends expected to impact the market outlook during the forecast. K Sreekumaran Nair, M.D., Ph.D., with Endocrinology, Diabetes, Metabolism & Nutrition at Mayo Clinic's campus in Rochester, Minnesota, says: "With the rapidly expanding prevalence of T2DM, many novel oral therapeutic agents are emerging, but metformin continues to dominate, both as monotherapy as well as in combination with other medications.